Congressional panel to investigate Tylenol’s recall

May 7th, 2010 - 8:54 pm ICT by Pen Men At Work  

fro May 7, 2010 (Pen Men at Work): The American House Oversight and Government Reform Committee will be examining the latest recall of the children’s cold medicine, Tylenol. The Congressional panel uttered that the consequence of Tylenol, if consumed by children, needs to be examined.

The American Food and Drug Administration (FDA) and the manufacturers of Tylenol, McNeil Consumer Healthcare, have been supplied incongruous accounts related to the circumstances of the recall, which consist of the raison d’être behind the action to recall the medicine and its gravity.

Queries have been created over FDA’s assessment methods as this is the third recall of Tylenol within a year. The examination will make out whether McNeil took notice of customer grievances and worries earlier.

Drug giant, McNeil Consumer Healthcare, has recalled more than forty of its products, including Tylenol, Motrin, Zyrtec and Benadryl recently. These products have been vended in the United States and eleven other countries.

FDA in its previous report divulged that McNeil purchased contaminated raw material that tested positive for bacteria. The agency later acknowledged the bacteria as Burkholderia cepacia. But McNeil has persevered that the contamination did not influence the final product. Reports have demonstrated contradictory particulars about the recall that has certainly questioned the state of affairs at McNeil’s Fort Washington, PA-based factory.

Related Stories

Tags: , , , , , , , , , , , , , , , , , , ,

Posted in Business, Health |